Palatin to investigate MC4R agonist as a potentially effective and safe treatment for obesityPalatin Technologies, a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of...
Fructose survival hypothesis driving obesityNutrition experts have recognized for many years that western diets rich in fats and sugar may be behind the cause of obesity, but debate...
Study uncovers new link between B12 deficiency and chronic inflammationA new study has identified a compelling link between vitamin B12 deficiency and chronic inflammation, which is associated with a range of...
Journal Watch 18/10/2023Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
WOF releases position statement addressing weight stigma and changing obesity narrativesThe World Obesity Federation has released position statement addressing weight stigma and changing obesity narratives. The statement,...
GLP-1/GIP candidate VK2735 shows reductions in subjects' liver fat content and plasma lipid levelsOutcomes from Viking Therapeutics’ Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial of VK2735 were...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes7 days ago